The application of body mass index-based eligibility criteria may represent an unjustified barrier to renal transplantation in people with obesity.


Journal

Clinical obesity
ISSN: 1758-8111
Titre abrégé: Clin Obes
Pays: England
ID NLM: 101560587

Informations de publication

Date de publication:
Apr 2022
Historique:
revised: 07 12 2021
received: 06 09 2021
accepted: 11 12 2021
pubmed: 30 12 2021
medline: 11 3 2022
entrez: 29 12 2021
Statut: ppublish

Résumé

The prevalence of both obesity and end-stage kidney disease is increasing. In many centres, obesity is considered a relative contraindication to kidney transplantation due to an association with short- and longer-term adverse outcomes. This leads to delayed transplant waitlisting and longer organ waiting times for people with obesity. This review evaluates whether intentional pre-transplant weight loss in people with obesity improves kidney transplant outcomes. There are currently no data showing that non-surgical weight loss of 10% or more improves graft or patient survival over 4-5 years. Outcomes from bariatric surgery cohorts have been generally neutral or favourable after pre-transplant weight loss of ~25%. Given the survival benefit of kidney transplantation compared to maintenance dialysis, and the difficulty of achieving and maintaining weight loss, the common practice of recommending weight loss to achieve arbitrary targets prior to waiting list activation needs to be carefully considered.

Identifiants

pubmed: 34964256
doi: 10.1111/cob.12505
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12505

Subventions

Organisme : National Health and Medical Research Council

Informations de copyright

© 2021 World Obesity Federation.

Références

Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642.
Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709-733.
Friedman AN, Miskulin DC, Rosenberg IH, Levey AS. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis. 2003;41(2):480-487.
Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73(1):19-33.
Redinger RN. The pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol (N Y). 2007;3(11):856-863.
Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2001;16(9):1790-1798.
Tsuboi N, Utsunomiya Y, Hosoya T. Obesity-related glomerulopathy and the nephron complement. Nephrol Dial Transplant 2013;28 Suppl 4:iv108-113, iv113.
D'Agati VD, Chagnac A, de Vries AP, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453-471.
Lafranca JA, JN IJ, Betjes MG, Dor FJ. Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis. BMC Med. 2015;13:111.
Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001;1(Suppl 2):3-95.
Knoll G, Cockfield S, Blydt-Hansen T, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173(10):1181-1184.
European Renal Best Practice Transplantation Guideline Development G. ERBP guideline on the management and evaluation of the kidney donor and recipient. Nephrol Dial Transplant 2013;28 Suppl 2:ii1-71, ii71.
Zealand TTSoAaN. Clinical Guidelines for Organ Transplantation from Deceased Donors 2020.
Dudley C, Harden P. Renal association clinical practice guideline on the assessment of the potential kidney transplant recipient. Nephron Clin Pract. 2011;118(Suppl 1):c209-c224.
Chadban SJ, Ahn C, Axelrod DA, et al. KDIGO clinical practice guideline on the evaluation and Management of Candidates for kidney transplantation. Transplantation. 2020;104((4S1 Suppl 1)):S11-S103.
Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010;77(4):299-311.
Ladhani M, Craig JC, Wong G. Obesity and gender-biased access to deceased donor kidney transplantation. Nephrol Dial Transplant. 2020;35(1):184-189.
Bolignano D, Zoccali C. Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant. 2013;28(4):iv82-iv98.
Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4(10):1565-1574.
Bray GA, Kim KK, Wilding JPH, World Obesity F. Obesity: a chronic relapsing progressive disease process. A position statement of the world obesity federation. Obes Rev. 2017;18(7):715-723.
Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007;107(10):1755-1767.
Orandi BJ, Purvis JW, Cannon RM, et al. Bariatric surgery to achieve transplant in end-stage organ disease patients: a systematic review and meta-analysis. Am J Surg. 2020;220(3):566-579.
Pelletier SJ, Maraschio MA, Schaubel DE, et al. Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin Transpl. 2003;77-88.
Gill JS, Lan J, Dong J, et al. The survival benefit of kidney transplantation in obese patients. Am J Transplant. 2013;13(8):2083-2090.
Lee S, Yoo KD, An JN, et al. Factors affecting mortality during the waiting time for kidney transplantation: a nationwide population-based cohort study using the Korean network for organ sharing (KONOS) database. PLoS One. 2019;14(4):e0212748.
Schold JD, Srinivas TR, Guerra G, et al. A "weight-listing" paradox for candidates of renal transplantation? Am J Transplant. 2007;7(3):550-559.
Huang E, Bunnapradist S. Pre-transplant weight loss and survival after kidney transplantation. Am J Nephrol. 2015;41(6):448-455.
Heng AE, Aniort J, Pereira B, Fervenza F, Boirie Y, Prieto M. Renal transplant in obese patients and impact of weight loss before surgery on surgical and medical outcomes: a single-center cohort study. Exp Clin Transplant. 2019;17(5):604-612.
Harhay MN, Ranganna K, Boyle SM, et al. Association between weight loss before deceased donor kidney transplantation and Posttransplantation outcomes. Am J Kidney Dis. 2019;74(3):361-372.
Kim Y, Jung AD, Dhar VK, et al. Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients. Am J Transplant. 2018;18(2):410-416.
Yemini R, Nesher E, Carmeli I, et al. Bariatric surgery is efficacious and improves access to transplantation for morbidly obese renal transplant candidates. Obes Surg. 2019;29(8):2373-2380.
Cohen JB, Lim MA, Tewksbury CM, et al. Bariatric surgery before and after kidney transplantation: long-term weight loss and allograft outcomes. Surg Obes Relat Dis. 2019;15(6):935-941.
Kim Y, Bailey AJ, Morris MC, Kassam AF, Shah SA, Diwan TS. Kidney transplantation after sleeve gastrectomy in the morbidly obese candidate: results of a 2-year experience. Surg Obes Relat Dis. 2020;16(1):10-14.
Gaillard M, Tranchart H, Beaudreuil S, et al. Laparoscopic sleeve gastrectomy for morbid obesity in renal transplantation candidates: a matched case-control study. Transpl Int. 2020;33(9):1061-1070.
Thomas IA, Gaynor JJ, Joseph T, et al. Roux-en-Y gastric bypass is an effective bridge to kidney transplantation: results from a single center. Clin Transplant. 2018;32(5):e13232.
Kassam AF, Mirza A, Kim Y, et al. Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy. Am J Transplant. 2020;20(2):422-429.
Bouchard P, Tchervenkov J, Demyttenaere S, Court O, Andalib A. Safety and efficacy of the sleeve gastrectomy as a strategy towards kidney transplantation. Surg Endosc. 2020;34(6):2657-2664.
Hajjar R, Lafrance JP, Tchervenkov J, et al. Successful surgical weight loss with laparoscopic sleeve gastrectomy for morbid obesity prior to kidney transplantation. Transpl Int. 2021;34:964-973.
Kienzl-Wagner K, Weissenbacher A, Gehwolf P, Wykypiel H, Ofner D, Schneeberger S. Laparoscopic sleeve gastrectomy: gateway to kidney transplantation. Surg Obes Relat Dis. 2017;13(6):909-915.
Outmani L, Kimenai H, Roodnat JI, et al. Clinical outcome of kidney transplantation after bariatric surgery: a single-center, retrospective cohort study. Clin Transplant. 2021;35(3):e14208.
Modanlou KA, Muthyala U, Xiao H, et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation. 2009;87(8):1167-1173.
Al-Bahri S, Fakhry TK, Gonzalvo JP, Murr MM. Bariatric surgery as a bridge to renal transplantation in patients with end-stage renal disease. Obes Surg. 2017;27(11):2951-2955.
Ladhani M, Craig JC, Irving M, Clayton PA, Wong G. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2017;32(3):439-449.
Neovius M, Jacobson SH, Eriksson JK, Elinder CG, Hylander B. Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study. BMJ Open. 2014;4(2):e004251.
Park J, Ahmadi SF, Streja E, et al. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis. 2014;56(4):415-425.
Park J. Kidney disease and obesity paradox. Kidney Res Clin Pract. 2017;36(1):1-2.
Registry A. 42nd Report, Chapter 7. Kidney Transplantation. Australia and New Zealand Dialysis and Transplant Registry; 2019.
Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA. 1993;270(11):1339-1343.
Haller MC, Kainz A, Baer H, Oberbauer R. Dialysis vintage and outcomes after kidney transplantation: a retrospective cohort study. Clin J Am Soc Nephrol. 2017;12(1):122-130.
Krishnan N, Higgins R, Short A, et al. Kidney transplantation significantly improves patient and graft survival irrespective of BMI: a cohort study. Am J Transplant. 2015;15(9):2378-2386.
Bennett WM, McEvoy KM, Henell KR, Pidikiti S, Douzdjian V, Batiuk T. Kidney transplantation in the morbidly obese: complicated but still better than dialysis. Clin Transplant. 2011;25(3):401-405.
Kim Y, Chang AL, Wima K, et al. The impact of morbid obesity on resource utilization after renal transplantation. Surgery. 2016;160(6):1544-1550.
Cannon RM, Jones CM, Hughes MG, Eng M, Marvin MR. The impact of recipient obesity on outcomes after renal transplantation. Ann Surg. 2013;257(5):978-984.
Lee Y, Raveendran L, Lovrics O, et al. The role of bariatric surgery on kidney transplantation: a systematic review and meta-analysis. Can Urol Assoc J. 2021;15:E553-E562.
Shirali AC, Bia MJ. Management of cardiovascular disease in renal transplant recipients. Clin J Am Soc Nephrol. 2008;3(2):491-504.
McCloskey OM, Devine PA, Courtney AE, McCaughan JA. Is big bad or bearable? Long-term renal transplant outcomes in obese recipients. QJM. 2018;111(6):365-371.
Flegal KM, Graubard BI. Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr. 2009;89(4):1213-1219.
Freedman DS, Katzmarzyk PT, Dietz WH, Srinivasan SR, Berenson GS. Relation of body mass index and skinfold thicknesses to cardiovascular disease risk factors in children: the Bogalusa heart study. Am J Clin Nutr. 2009;90(1):210-216.
Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275-286.
Amato MC, Guarnotta V, Giordano C. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Invest. 2013;36(7):537-543.
Androga L, Sharma D, Amodu A, Abramowitz MK. Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease. Kidney Int Rep. 2017;2(2):201-211.
Lesage J, Gill JS. Management of the obese kidney transplant candidate. Transplant Rev (Orlando). 2017;31(1):35-41.
Song R, Nolan BJ, Harb H, Sumithran P. Intensive management of obesity in people with severe chronic kidney disease: a review. Diabetes Obes Metab. 2021;23(8):1733-1745.
MacLaughlin HL, Cook SA, Kariyawasam D, Roseke M, van Niekerk M, Macdougall IC. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up. Am J Kidney Dis. 2010;55(1):69-76.
Hajjar R, Marcotte C, Chan G. Conservative Management of Obesity in kidney transplant candidates. J Ren Nutr. 2021. doi:10.1053/j.jrn.2021.03.005
Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481-1486.
Lean MEJ, Astrup A, Roberts SB. Making progress on the global crisis of obesity and weight management. BMJ. 2018;361:k2538.
Gazzetta PG, Bissolati M, Saibene A, et al. Bariatric surgery to target obesity in the renal transplant population: preliminary experience in a single center. Transplant Proc. 2017;49(4):646-649.
Szomstein S, Rojas R, Rosenthal RJ. Outcomes of laparoscopic bariatric surgery after renal transplant. Obes Surg. 2010;20(3):383-385.

Auteurs

Alanna Tan (A)

Department of Endocrinology, Austin Health, Melbourne, Victoria, Australia.

Scott Wilson (S)

Department of Nephrology, Alfred Health, Melbourne, Victoria, Australia.
Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Priya Sumithran (P)

Department of Endocrinology, Austin Health, Melbourne, Victoria, Australia.
Department of Medicine (St Vincent's), University of Melbourne, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH